FDA Inspection
Ajanta Pharma Ltd.Ajanta Pharma Ltd. – FDA Inspection, Apr 21, 2026
Record Details
This FDA Inspection record concerns Ajanta Pharma Ltd., with an inspection on April 21, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 6118c3f9-60aa-44a4-ae82-113ff53e50a0
Inspection Facts
- Inspection number
- 1313426
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.100(b)SOPs not followed / documented
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ajanta Pharma Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2017 | NAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| March 20, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 6, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ajanta Pharma Ltd.
- FDA Inspection 1235564 - 2024-03-05
- FDA Inspection 1097061 - 2019-06-28
- FDA Inspection 1009806 - 2017-02-07
- FDA Inspection 917795 - 2015-03-20
- FDA Inspection 801522 - 2012-09-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.